AAPS 2025 PharmSci 360

November 9-12, 2025

San Antonio, TX

Visit us at BOOTH #2725

Request a meeting with our on-site team to learn how we help our clients advance their therapeutic drug programs.

APPS PharmSci 360 logo white

Presentations by BioAgilytix

SYMPOSIUM PRESENTATIONS
Jessica and Reema
Manufacturing & Analytical Characterization
Proven Control Strategies for ADC/mAb Potency and HCP Analysis
Jessica Weaver, MRes, Scientific Officer
Reema Davis, PhD, Scientific Operations   
Tuesday, November 11, 11:15-12:00 PM 
Location: Stage B


Amanda Hays
Biomarker, Platform and Support
Bioanalytical Assays for Gene Therapy Shedding Studies: Platforms and Validation
Amanda Hays, PhD, Scientific Officer  
Tuesday, November 11, 9:00-9:30 AM  
Location: 221AB 

Liz Nolff
Oligo Bioanalysis, Platforms and Methods
Comparison of Two Hybridization LBA Platforms for Oligonucleotide Therapeutic Quantification 
Liz Nolff, MS, Scientific Operations  
Wednesday, November 12, 10:00-10:30 AM  
Location: 221AB 

POSTER PRESENTATIONS
Abbas Kabir from BioAgilytix-1
(M1130-01-03) Custom MSD U-PLEX for the Quantitation of CXCL3, CXCL5, and CXCL10 in Human CSF 
Abbas Kabir, PhD, Scientific Operations  
Monday, November 10, 11:30-12:30 PM 


Shruti Patel from BioAgylitix
(T1530-02-09) Validating the Measurement of Loss of Cell Surface CD6 on CD4 T-Cell Based Potency Assay Using Flow Cytometry 
Shruti Patel, MS, Scientific Operations 
Tuesday, November 11, 3:30-4:30 PM 
 

SPECIAL POSTER COLLECTION
lynn-Kamen
Advances in Translational Biology to Advance from the Bench to the Bedside 
Lynn Kamen, PhD, Scientific Officer  
Monday, November 10, 12:30-1:25 PM 
Poster Forum 4, Exhibit Halls 3 & 4
MODERATOR
Brian Gullick from BioAgilytix
Rapid Fire Presentation
Novel Instrumentations in Bioanalysis/Oligo Bioanalysis, Platforms and Methods 
Bryan Gullick, PhD, Director  
Wednesday, November 12, 3:00-4:00 PM 
Location: 221AB 

Customized approaches to support your bioanalytical needs

As a leading global bioanalytical laboratory, we provide pharmaceutical and biotech organizations with the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services.    
 
Our labs offer immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, eliminating the need for multiple providers and ensuring the efficient delivery of data for your therapeutic study.    
 
Our scientific expertise and state-of-the-art instrumentation result in high-quality, tailored services starting with early preclinical testing and partnering with you all the way through the late clinical stages of your drug program.    
 
We partner with you to build the right bioanalytical package for your program based on the current regulatory standards, from GMP, GLP, GCP, to CLIA and IDE/IVDR.     

Schedule a meeting with our experts on site

Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.

About the event 

AAPS PharmSci 360 is one of the premier scientific conferences for pharmaceutical scientists and bioanalytical experts. Taking place from November 9 to 12, 2025, in San Antonio, Texas, this event brings together thought leaders in drug development, bioanalysis, and CMC analytics to explore the latest advancements across all stages of the pharmaceutical lifecycle. BioAgilytix will showcase our GxP-compliant bioanalytical and CMC analytical services supporting large molecule, cell and gene therapy, and complex biologic programs. Visit our booth to connect with our scientific team and learn how our robust assay development, pharmacokinetics, immunogenicity, biomarkers, and QC testing capabilities can support your molecule from discovery through commercialization. 

Learn more about this event on their website

AAPS PharmSci 360 2025 in San Antonio, TX

 

Schedule a meeting with our experts on site

Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.